Trial intelligence / Profile preview

Amlodipine 5mg vs 10mg in Essential Hypertension

NCT00415623Phase 3Completed

Sponsor
Viatris
Start
Jan 2007
Primary completion
Oct 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of amlodipine in essential hypertension, sponsored by Viatris. Started Jan 2007; status: completed.

02

Drugs

amlodipine
03

Conditions

essential hypertension

Beyond the preview

Go deeper on NCT00415623.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00415623.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call